Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum OrganiGram Holdings Inc T.OGI

Alternate Symbol(s):  OGI

Organigram Holdings Inc. is focused on producing cannabis for patients and adult-recreational consumers, as well as developing international business partnerships to extend the Company's global footprint. The Company, through its subsidiary, Organigram Inc., is a licensed producer of cannabis, cannabis- derived products and cannabis infused edibles in Canada. It has also developed and acquired... see more

TSX:OGI - Post Discussion

OrganiGram Holdings Inc > The news i just read
View:
Post by sylvain_007 on Mar 11, 2021 8:09pm

The news i just read

Organigram Holdings Inc's U.S.-listed shares OGI, +39.79% soared 47% in premarket trade Thursday, after the Canadian cannabis company said it has received a C$221 million ($176.6 million) investment from a unit of British American Tobacco PLC BATS, +0.38% BTI, -0.27%. The tobacco company has subscribed for about 58.3 million shares of Organigram, equal to a 19.9% stake at a price per share of C$3.792, based on a five-day volume weighted average price on the TSX ending March 9, 2021. Organigram shares closed Wednesday at $2.89. As part of the deal, the companies have entered a product development collaboration agreement, and will create a Center of Excellence to work together to develop the next generation of cannabis products, focused initially on CBD. "Both companies will contribute scientists, researchers, and product developers to the Center of Excellence which will be governed and supervised by a steering committee," the two companies said in a statement. They will each have access to each other's intellectual property. BAT will have the right to appoint 20% of the Organigram board, as long as it maintains at least 15% of its outstanding shares. Organigram is expecting the deal to help it expand overseas including into the U.S. market. Organigram shares have gained 68% in the last 12 months, while the Cannabis ETF THCX, +8.39% has gained 151% and the S&P 500 SPX, +1.04% has gained 42%.
Comment by QuantumTime on Mar 11, 2021 8:41pm
OGI finally has a pathway for multiple products and new products to be sold on the U.S. market.  Love it.
Comment by Sinterklaas on Mar 12, 2021 12:24am
Forget the US market. Try the planet.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities